The H50Q mutation induces a 10-fold decrease in the solubility of α-synuclein.

Synuclein, alpha (non A4 component of amyloid precursor) [Homo sapiens]

alpha-synuclein isoform NACP140 [Homo sapiens]

RecName: Full=Alpha-synuclein; AltName: Full=Non-A beta component of AD amyloid; AltName: Full=Non-A4 component of amyloid prec

1H, 13C, and 15N chemical shift assignments for alpha-synuclein monomer (WT)

Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, UCL

Department of Structural and Molecular Biology, UCL

Department of Clinical Neuroscience, Institute of Neurology, UCL

Centre for Genomic Regulation and University Pompeu Fabra

Department of Molecular Medicine, Institute of Biochemistry, University of Pavia

Department of Chemistry, University of Cambridge

Department of Physics, University of Genoa

The CCPN NMR assignment and data analysis application

Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

Department of Biochemistry, Cambridge CB2 1GA, UK